United States Bevacizumab Market Report 2016

December 2016 | 101 pages | ID: UB35F462409EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Bevacizumab

Revenue, means the sales value of Bevacizumab

This report studies sales (consumption) of Bevacizumab in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• Biocon
• Bionomics
• Amgen
• Genexine
• Levolta Pharmaceuticals
• Enzon Pharmaceuticals
• Marsala Biotech
• Mabtech
• Fujifilm Kyowa Kirin Biologics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Bevacizumab in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Bevacizumab Market Report 2016

1 BEVACIZUMAB OVERVIEW

1.1 Product Overview and Scope of Bevacizumab
1.2 Classification of Bevacizumab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Bevacizumab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Bevacizumab (2011-2021)
  1.4.1 United States Bevacizumab Sales and Growth Rate (2011-2021)
  1.4.2 United States Bevacizumab Revenue and Growth Rate (2011-2021)

2 UNITED STATES BEVACIZUMAB COMPETITION BY MANUFACTURERS

2.1 United States Bevacizumab Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Bevacizumab Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Bevacizumab Average Price by Manufactures (2015 and 2016)
2.4 Bevacizumab Market Competitive Situation and Trends
  2.4.1 Bevacizumab Market Concentration Rate
  2.4.2 Bevacizumab Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES BEVACIZUMAB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Bevacizumab Sales and Market Share by Type (2011-2016)
3.2 United States Bevacizumab Revenue and Market Share by Type (2011-2016)
3.3 United States Bevacizumab Price by Type (2011-2016)
3.4 United States Bevacizumab Sales Growth Rate by Type (2011-2016)

4 UNITED STATES BEVACIZUMAB SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Bevacizumab Sales and Market Share by Application (2011-2016)
4.2 United States Bevacizumab Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES BEVACIZUMAB MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Bevacizumab Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Biocon
  5.2.2 Bevacizumab Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Biocon Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Bionomics
  5.3.2 Bevacizumab Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Bionomics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Amgen
  5.4.2 Bevacizumab Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Amgen Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Genexine
  5.5.2 Bevacizumab Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Genexine Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Levolta Pharmaceuticals
  5.6.2 Bevacizumab Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Levolta Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Enzon Pharmaceuticals
  5.7.2 Bevacizumab Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Enzon Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Marsala Biotech
  5.8.2 Bevacizumab Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Marsala Biotech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Mabtech
  5.9.2 Bevacizumab Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Mabtech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Fujifilm Kyowa Kirin Biologics
  5.10.2 Bevacizumab Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Fujifilm Kyowa Kirin Biologics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 BEVACIZUMAB MANUFACTURING COST ANALYSIS

6.1 Bevacizumab Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Bevacizumab

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Bevacizumab Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Bevacizumab Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES BEVACIZUMAB MARKET FORECAST (2016-2021)

10.1 United States Bevacizumab Sales, Revenue Forecast (2016-2021)
10.2 United States Bevacizumab Sales Forecast by Type (2016-2021)
10.3 United States Bevacizumab Sales Forecast by Application (2016-2021)
10.4 Bevacizumab Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bevacizumab
Table Classification of Bevacizumab
Figure United States Sales Market Share of Bevacizumab by Type in 2015
Table Application of Bevacizumab
Figure United States Sales Market Share of Bevacizumab by Application in 2015
Figure United States Bevacizumab Sales and Growth Rate (2011-2021)
Figure United States Bevacizumab Revenue and Growth Rate (2011-2021)
Table United States Bevacizumab Sales of Key Manufacturers (2015 and 2016)
Table United States Bevacizumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bevacizumab Sales Share by Manufacturers
Figure 2016 Bevacizumab Sales Share by Manufacturers
Table United States Bevacizumab Revenue by Manufacturers (2015 and 2016)
Table United States Bevacizumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Bevacizumab Revenue Share by Manufacturers
Table 2016 United States Bevacizumab Revenue Share by Manufacturers
Table United States Market Bevacizumab Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Bevacizumab Average Price of Key Manufacturers in 2015
Figure Bevacizumab Market Share of Top 3 Manufacturers
Figure Bevacizumab Market Share of Top 5 Manufacturers
Table United States Bevacizumab Sales by Type (2011-2016)
Table United States Bevacizumab Sales Share by Type (2011-2016)
Figure United States Bevacizumab Sales Market Share by Type in 2015
Table United States Bevacizumab Revenue and Market Share by Type (2011-2016)
Table United States Bevacizumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Bevacizumab by Type (2011-2016)
Table United States Bevacizumab Price by Type (2011-2016)
Figure United States Bevacizumab Sales Growth Rate by Type (2011-2016)
Table United States Bevacizumab Sales by Application (2011-2016)
Table United States Bevacizumab Sales Market Share by Application (2011-2016)
Figure United States Bevacizumab Sales Market Share by Application in 2015
Table United States Bevacizumab Sales Growth Rate by Application (2011-2016)
Figure United States Bevacizumab Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Bevacizumab Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Bevacizumab Sales Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionomics Bevacizumab Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Bevacizumab Sales Market Share (2011-2016)
Table Genexine Basic Information List
Table Genexine Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genexine Bevacizumab Sales Market Share (2011-2016)
Table Levolta Pharmaceuticals Basic Information List
Table Levolta Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Levolta Pharmaceuticals Bevacizumab Sales Market Share (2011-2016)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Enzon Pharmaceuticals Bevacizumab Sales Market Share (2011-2016)
Table Marsala Biotech Basic Information List
Table Marsala Biotech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Marsala Biotech Bevacizumab Sales Market Share (2011-2016)
Table Mabtech Basic Information List
Table Mabtech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mabtech Bevacizumab Sales Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Bevacizumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bevacizumab
Figure Manufacturing Process Analysis of Bevacizumab
Figure Bevacizumab Industrial Chain Analysis
Table Raw Materials Sources of Bevacizumab Major Manufacturers in 2015
Table Major Buyers of Bevacizumab
Table Distributors/Traders List
Figure United States Bevacizumab Production and Growth Rate Forecast (2016-2021)
Figure United States Bevacizumab Revenue and Growth Rate Forecast (2016-2021)
Table United States Bevacizumab Production Forecast by Type (2016-2021)
Table United States Bevacizumab Consumption Forecast by Application (2016-2021)